Global Anesthesia Drugs Market 2023-2027

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global anesthesia drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global anesthesia drugs market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Route of Administration Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 General anesthesia - Market size and forecast 2022-2027
Exhibit 34: Chart on General anesthesia - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on General anesthesia - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on General anesthesia - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on General anesthesia - Year-over-year growth 2022-2027 (%)
6.4 Local and regional anesthesia - Market size and forecast 2022-2027
Exhibit 38: Chart on Local and regional anesthesia - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Local and regional anesthesia - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Local and regional anesthesia - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Local and regional anesthesia - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)

7 Market Segmentation by Route of Administration
7.1 Market segments
Exhibit 43: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 44: Data Table on Route of Administration - Market share 2022-2027 (%)
7.2 Comparison by Route of Administration
Exhibit 45: Chart on Comparison by Route of Administration
Exhibit 46: Data Table on Comparison by Route of Administration
7.3 Intravenous - Market size and forecast 2022-2027
Exhibit 47: Chart on Intravenous - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Intravenous - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Intravenous - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Intravenous - Year-over-year growth 2022-2027 (%)
7.4 Inhalational - Market size and forecast 2022-2027
Exhibit 51: Chart on Inhalational - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Inhalational - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Inhalational - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Inhalational - Year-over-year growth 2022-2027 (%)
7.5 Others - Market size and forecast 2022-2027
Exhibit 55: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Route of Administration
Exhibit 59: Market opportunity by Route of Administration ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 61: Chart on Market share by geography 2022-2027 (%)
Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 63: Chart on Geographic comparison
Exhibit 64: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 89: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 India - Market size and forecast 2022-2027
Exhibit 97: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on India - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 101: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 102: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 104: Overview on factors of disruption
11.4 Industry risks
Exhibit 105: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 106: Vendors covered
12.2 Market positioning of vendors
Exhibit 107: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 108: AbbVie Inc. - Overview
Exhibit 109: AbbVie Inc. - Product / Service
Exhibit 110: AbbVie Inc. - Key news
Exhibit 111: AbbVie Inc. - Key offerings
12.4 AstraZeneca Plc
Exhibit 112: AstraZeneca Plc - Overview
Exhibit 113: AstraZeneca Plc - Product / Service
Exhibit 114: AstraZeneca Plc - Key news
Exhibit 115: AstraZeneca Plc - Key offerings
12.5 Avet Pharmaceuticals Inc.
Exhibit 116: Avet Pharmaceuticals Inc. - Overview
Exhibit 117: Avet Pharmaceuticals Inc. - Product / Service
Exhibit 118: Avet Pharmaceuticals Inc. - Key offerings
12.6 B Braun Melsungen AG
Exhibit 119: B Braun Melsungen AG - Overview
Exhibit 120: B Braun Melsungen AG - Business segments
Exhibit 121: B Braun Melsungen AG - Key news
Exhibit 122: B Braun Melsungen AG - Key offerings
Exhibit 123: B Braun Melsungen AG - Segment focus
12.7 Baxter International Inc.
Exhibit 124: Baxter International Inc. - Overview
Exhibit 125: Baxter International Inc. - Business segments
Exhibit 126: Baxter International Inc. - Key news
Exhibit 127: Baxter International Inc. - Key offerings
Exhibit 128: Baxter International Inc. - Segment focus
12.8 Eisai Co. Ltd.
Exhibit 129: Eisai Co. Ltd. - Overview
Exhibit 130: Eisai Co. Ltd. - Business segments
Exhibit 131: Eisai Co. Ltd. - Key offerings
Exhibit 132: Eisai Co. Ltd. - Segment focus
12.9 Fresenius SE and Co. KGaA
Exhibit 133: Fresenius SE and Co. KGaA - Overview
Exhibit 134: Fresenius SE and Co. KGaA - Business segments
Exhibit 135: Fresenius SE and Co. KGaA - Key news
Exhibit 136: Fresenius SE and Co. KGaA - Key offerings
Exhibit 137: Fresenius SE and Co. KGaA - Segment focus
12.10 Glenmark Pharmaceuticals Ltd.
Exhibit 138: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 139: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 140: Glenmark Pharmaceuticals Ltd. - Key offerings
12.11 Hikma Pharmaceuticals Plc
Exhibit 141: Hikma Pharmaceuticals Plc - Overview
Exhibit 142: Hikma Pharmaceuticals Plc - Business segments
Exhibit 143: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 144: Hikma Pharmaceuticals Plc - Segment focus
12.12 Maruishi Pharmaceutical Co. Ltd.
Exhibit 145: Maruishi Pharmaceutical Co. Ltd. - Overview
Exhibit 146: Maruishi Pharmaceutical Co. Ltd. - Product / Service
Exhibit 147: Maruishi Pharmaceutical Co. Ltd. - Key offerings
12.13 Merck and Co. Inc.
Exhibit 148: Merck and Co. Inc. - Overview
Exhibit 149: Merck and Co. Inc. - Business segments
Exhibit 150: Merck and Co. Inc. - Key news
Exhibit 151: Merck and Co. Inc. - Key offerings
Exhibit 152: Merck and Co. Inc. - Segment focus
12.14 Novartis AG
Exhibit 153: Novartis AG - Overview
Exhibit 154: Novartis AG - Business segments
Exhibit 155: Novartis AG - Key offerings
Exhibit 156: Novartis AG - Segment focus
12.15 Pfizer Inc.
Exhibit 157: Pfizer Inc. - Overview
Exhibit 158: Pfizer Inc. - Product / Service
Exhibit 159: Pfizer Inc. - Key news
Exhibit 160: Pfizer Inc. - Key offerings
12.16 Piramal Enterprises Ltd.
Exhibit 161: Piramal Enterprises Ltd. - Overview
Exhibit 162: Piramal Enterprises Ltd. - Business segments
Exhibit 163: Piramal Enterprises Ltd. - Key offerings
Exhibit 164: Piramal Enterprises Ltd. - Segment focus
12.17 Septodont Holding
Exhibit 165: Septodont Holding - Overview
Exhibit 166: Septodont Holding - Product / Service
Exhibit 167: Septodont Holding - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 168: Inclusions checklist
Exhibit 169: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 170: Currency conversion rates for US$
13.4 Research methodology
Exhibit 171: Research methodology
Exhibit 172: Validation techniques employed for market sizing
Exhibit 173: Information sources
13.5 List of abbreviations
Exhibit 174: List of abbreviations

List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global anesthesia drugs market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Type - Market share 2022-2027 (%)
Exhibits 31: Data Table on Type - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on General anesthesia - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on General anesthesia - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on General anesthesia - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on General anesthesia - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Local and regional anesthesia - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Local and regional anesthesia - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Local and regional anesthesia - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Local and regional anesthesia - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Type ($ million)
Exhibits 43: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits 44: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits 45: Chart on Comparison by Route of Administration
Exhibits 46: Data Table on Comparison by Route of Administration
Exhibits 47: Chart on Intravenous - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Data Table on Intravenous - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Chart on Intravenous - Year-over-year growth 2022-2027 (%)
Exhibits 50: Data Table on Intravenous - Year-over-year growth 2022-2027 (%)
Exhibits 51: Chart on Inhalational - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Data Table on Inhalational - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Chart on Inhalational - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on Inhalational - Year-over-year growth 2022-2027 (%)
Exhibits 55: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 56: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 58: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 59: Market opportunity by Route of Administration ($ million)
Exhibits 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 61: Chart on Market share by geography 2022-2027 (%)
Exhibits 62: Data Table on Market share by geography 2022-2027 (%)
Exhibits 63: Chart on Geographic comparison
Exhibits 64: Data Table on Geographic comparison
Exhibits 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 97: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibits 98: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibits 99: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits 100: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits 101: Market opportunity by geography ($ million)
Exhibits 102: Impact of drivers and challenges in 2022 and 2027
Exhibits 103: Overview on Criticality of inputs and Factors of differentiation
Exhibits 104: Overview on factors of disruption
Exhibits 105: Impact of key risks on business
Exhibits 106: Vendors covered
Exhibits 107: Matrix on vendor position and classification
Exhibits 108: AbbVie Inc. - Overview
Exhibits 109: AbbVie Inc. - Product / Service
Exhibits 110: AbbVie Inc. - Key news
Exhibits 111: AbbVie Inc. - Key offerings
Exhibits 112: AstraZeneca Plc - Overview
Exhibits 113: AstraZeneca Plc - Product / Service
Exhibits 114: AstraZeneca Plc - Key news
Exhibits 115: AstraZeneca Plc - Key offerings
Exhibits 116: Avet Pharmaceuticals Inc. - Overview
Exhibits 117: Avet Pharmaceuticals Inc. - Product / Service
Exhibits 118: Avet Pharmaceuticals Inc. - Key offerings
Exhibits 119: B Braun Melsungen AG - Overview
Exhibits 120: B Braun Melsungen AG - Business segments
Exhibits 121: B Braun Melsungen AG - Key news
Exhibits 122: B Braun Melsungen AG - Key offerings
Exhibits 123: B Braun Melsungen AG - Segment focus
Exhibits 124: Baxter International Inc. - Overview
Exhibits 125: Baxter International Inc. - Business segments
Exhibits 126: Baxter International Inc. - Key news
Exhibits 127: Baxter International Inc. - Key offerings
Exhibits 128: Baxter International Inc. - Segment focus
Exhibits 129: Eisai Co. Ltd. - Overview
Exhibits 130: Eisai Co. Ltd. - Business segments
Exhibits 131: Eisai Co. Ltd. - Key offerings
Exhibits 132: Eisai Co. Ltd. - Segment focus
Exhibits 133: Fresenius SE and Co. KGaA - Overview
Exhibits 134: Fresenius SE and Co. KGaA - Business segments
Exhibits 135: Fresenius SE and Co. KGaA - Key news
Exhibits 136: Fresenius SE and Co. KGaA - Key offerings
Exhibits 137: Fresenius SE and Co. KGaA - Segment focus
Exhibits 138: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits 139: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits 140: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits 141: Hikma Pharmaceuticals Plc - Overview
Exhibits 142: Hikma Pharmaceuticals Plc - Business segments
Exhibits 143: Hikma Pharmaceuticals Plc - Key offerings
Exhibits 144: Hikma Pharmaceuticals Plc - Segment focus
Exhibits 145: Maruishi Pharmaceutical Co. Ltd. - Overview
Exhibits 146: Maruishi Pharmaceutical Co. Ltd. - Product / Service
Exhibits 147: Maruishi Pharmaceutical Co. Ltd. - Key offerings
Exhibits 148: Merck and Co. Inc. - Overview
Exhibits 149: Merck and Co. Inc. - Business segments
Exhibits 150: Merck and Co. Inc. - Key news
Exhibits 151: Merck and Co. Inc. - Key offerings
Exhibits 152: Merck and Co. Inc. - Segment focus
Exhibits 153: Novartis AG - Overview
Exhibits 154: Novartis AG - Business segments
Exhibits 155: Novartis AG - Key offerings
Exhibits 156: Novartis AG - Segment focus
Exhibits 157: Pfizer Inc. - Overview
Exhibits 158: Pfizer Inc. - Product / Service
Exhibits 159: Pfizer Inc. - Key news
Exhibits 160: Pfizer Inc. - Key offerings
Exhibits 161: Piramal Enterprises Ltd. - Overview
Exhibits 162: Piramal Enterprises Ltd. - Business segments
Exhibits 163: Piramal Enterprises Ltd. - Key offerings
Exhibits 164: Piramal Enterprises Ltd. - Segment focus
Exhibits 165: Septodont Holding - Overview
Exhibits 166: Septodont Holding - Product / Service
Exhibits 167: Septodont Holding - Key offerings
Exhibits 168: Inclusions checklist
Exhibits 169: Exclusions checklist
Exhibits 170: Currency conversion rates for US$
Exhibits 171: Research methodology
Exhibits 172: Validation techniques employed for market sizing
Exhibits 173: Information sources
Exhibits 174: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global anesthesia drugs market: AbbVie Inc., Aspen Pharmacare Holdings Ltd, AstraZeneca Plc, Avet Pharmaceuticals Inc., Baxter International Inc., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Endo International Plc, Fresenius SE and Co. KGaA, Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals Plc, Maruishi Pharmaceutical Co. Ltd., Merck and Co. Inc., Novartis AG, PAION AG, Pfizer Inc., Piramal Enterprises Ltd., Septodont Holding, Troikaa Pharmaceuticals Ltd., and B Braun Melsungen AG.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing adoption of alternatives to general anesthesia.`

According to the report, one of the major drivers for this market is the rising prevalence of cancer.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

• AbbVie Inc.
• Aspen Pharmacare Holdings Ltd
• AstraZeneca Plc
• Avet Pharmaceuticals Inc.
• Baxter International Inc.
• Dr Reddys Laboratories Ltd.
• Eisai Co. Ltd.
• Endo International Plc
• Fresenius SE and Co. KGaA
• Glenmark Pharmaceuticals Ltd.
• Hikma Pharmaceuticals Plc
• Maruishi Pharmaceutical Co. Ltd.
• Merck and Co. Inc.
• Novartis AG
• PAION AG
• Pfizer Inc.
• Piramal Enterprises Ltd.
• Septodont Holding
• Troikaa Pharmaceuticals Ltd.
• B Braun Melsungen AG